Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin?

This new study from Heidelberg (Wick et al.)  is the first orthotopic mouse GBM study I've seen with dihydroartemisinin (the main metabolite of the artemisinin compounds), although this was injected rather than give orally to the mice.

Also this is the first study I've seen showing exercise can improve the therapeutic effect of temozolomide.

Click here to view the study